Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Sham Controlled Trial of tDCS for Treatment of Negative Symptoms in Patients With Schizophrenia

NCT02204787 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02204787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02204787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Sham Controlled Trial of tDCS for Treatment of Negative Symptoms in Patients With Schizophrenia
Lead sponsor
University Hospital, Montpellier
Phase
Phase 1/2
Overall status
Completed
Start date
April 1, 2014
Completion date
October 26, 2018
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia